Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA) Total Costs & Expenses & History | Stock Alarm

Demo Sign up Log In

Teva Pharmaceutical Industries Limited American Depositary Shares · Total Costs & Expenses

TEVA Total Costs & Expenses

Latest reported$15.33Bperiod endingJun 30, 2026

TEVA Total Costs & Expenses ($79.30M → $15.33B)

Annual Total Costs & Expenses

High-resolution chart · PNG

TEVA total costs & expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Teva Pharmaceutical Industries Limited American Depositary Shares Total Costs & Expenses — Annual fiscal periods (USD)
Period ending	Total Costs & Expenses (USD)
Dec 31, 2025	15,100,000,000
Dec 31, 2024	16,847,000,000
Dec 31, 2023	15,412,000,000
Dec 31, 2022	17,122,000,000
Dec 31, 2021	14,162,000,000
Dec 31, 2020	20,231,000,000
Dec 31, 2019	17,330,000,000
Dec 31, 2018	15,985,000,000
Dec 31, 2017	18,394,000,000
Dec 31, 2016	17,251,000,000
Dec 31, 2015	14,538,000,000
Dec 31, 2014	15,782,000,000
Dec 31, 2013	16,353,000,000
Dec 31, 2012	16,138,000,000
Dec 31, 2011	14,302,000,000
Dec 31, 2010	11,822,000,000
Dec 31, 2009	10,833,000,000
Dec 31, 2008	9,940,000,000
Dec 31, 2007	7,013,000,000
Dec 31, 2006	6,312,000,000
Dec 31, 2005	3,937,500,000
Dec 31, 2004	3,624,500,000
Dec 31, 2003	2,391,600,000
Dec 31, 2002	1,994,600,000
Dec 31, 2001	1,700,914,000
Dec 31, 2000	1,374,644,000
Dec 31, 1999	1,083,360,000
Dec 31, 1998	970,900,000
Dec 31, 1997	943,100,000
Dec 31, 1996	824,500,000
Dec 31, 1995	552,500,000
Dec 31, 1994	481,000,000
Dec 31, 1993	414,000,000
Dec 31, 1992	350,700,000
Dec 31, 1991	275,000,000
Dec 31, 1990	288,700,000
Dec 31, 1989	236,900,000
Dec 31, 1988	188,600,000
Dec 31, 1986	120,300,000
Dec 31, 1985	79,300,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.